Finger prick blood test trial ‘could revolutionise’ Alzheimer’s diagnosis, say experts

Published loading…Updated

The Bio-Hermes-002 trial has enrolled 883 participants to validate a finger-prick test measuring three biomarkers against standard invasive diagnostics.

Continue Reading


News Source: ground.news

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *